Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine
about
Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite proteinMultistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaquesA randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adultsSynthetic DNA vaccine strategies against persistent viral infectionsCharacterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus MacaquesThe March Toward Malaria VaccinesImpact of immunization technology and assay application on antibody performance--a systematic comparative evaluationDNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.DNA and RNA-based vaccines: principles, progress and prospects.Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65)Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus AnkaraComplete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigenSubdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite.Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodiesInfectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trialsEnhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosisProtection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosaImmunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosisEvaluation of approaches to identify the targets of cellular immunity on a proteome-wide scale.Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimenAdjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity.Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyDevelopment of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replicationVaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria modelA nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malariaThe efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.Mice deficient in interleukin-4 (IL-4) or IL-4 receptor alpha have higher resistance to sporozoite infection with Plasmodium berghei (ANKA) than do naive wild-type mice.Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.Protective and pathogenic roles of CD8+ T cells during malaria infection.
P2860
Q24514954-C7978114-B97D-4DB2-A887-495711211F97Q24548638-B2921EC5-F974-4DA2-BA5D-C6AE8E56DFCCQ24804936-E5A3F59E-F6B7-4370-8157-6C4AFC0A15E6Q27016078-788A87D5-787C-4397-B841-F9911C1ACBF1Q27477541-1F0C2516-D5EA-43F8-B62B-E99990605112Q28084325-BD9F7E56-BCF5-41A6-9AA9-523705B190ECQ28741074-CE6F8E30-6CB5-4301-8A1F-F8C843C32F93Q33268303-94EDF79D-95B3-4CB4-84A4-67FE78F2617FQ33303670-C433C95A-838A-4884-AFFC-C111DD00BFF1Q33776098-55357C2A-F9DE-4376-AE7D-1DB4BC6B9DEBQ33783789-E69FD903-E466-48D8-B8ED-51D385CE4F36Q33802461-7958367A-DFA7-49EA-BCEF-06B11AD8CADDQ33806715-18F40E13-58AB-45B4-9013-A9CC5236C58EQ33868760-DE4CB3F2-2F2A-4D2E-A6AB-82ED1BBF88C9Q33935092-5BAB5C18-5F4E-468D-959F-E37300E06573Q33944652-905D6A29-2617-4E8D-88DB-E3545D599741Q33968196-6E79E009-A21D-414C-8FBB-F73DC79B51C4Q34000822-1E2F25DE-521A-4E56-BCD8-D53AA5673E64Q34001568-86A2B435-3BBE-4A7C-ACC2-CB3B31F98949Q34005845-31DC122D-A47F-4985-BE1F-FE79AEB4CC48Q34007482-69960DD5-2318-44EA-B6AE-A5F7121852A9Q34007894-328B08FA-AFA1-4158-9D63-DB6E77021BADQ34008163-EED4CB43-B625-4ED2-A225-E2EA492AC813Q34078008-9A18B227-FFBC-4FE8-A81E-946848E8742AQ34126483-51797BCD-38BF-48FE-B361-213999EAE7D6Q34129094-F5973BC1-35E4-49E0-BD31-BDB058B9D0D5Q34274515-5EBA442A-71F1-4CBE-B40A-C52206AB7E17Q34280935-77147117-116E-4244-93A0-854397BAC415Q34332119-36830E11-489C-442B-80EF-EA50B7DC1236Q34338715-5B69AAA3-7AAF-42E5-8D90-37CA144035C0Q34398787-459C5005-CF8A-4D8F-B893-955B7094E88CQ34469817-90DB3F3A-E963-4FED-B729-5C726008B0EFQ34482074-57117208-55CF-4F64-B048-03EBF851D4E7Q34983659-7937656B-B712-4CEB-BB47-B0CCA0DABD93Q35073970-A8DC54E9-5D10-49B8-B5A3-E1D787DA565BQ35122498-15A9214F-369E-4F48-8EF7-7F2188F527F8Q36226846-5FACEF39-9F4A-416E-A5C7-A6A61ECEA9EBQ36228933-ABF19414-0480-4FBF-937E-16379324143BQ36285998-5A881516-9E6F-48AF-9D3C-8097268173D2Q36378328-F1499197-7252-4E94-A0BB-CEB9890C32B8
P2860
Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@ast
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@en
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@nl
type
label
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@ast
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@en
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@nl
prefLabel
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@ast
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@en
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@nl
P2093
P2860
P356
P1476
Boosting with recombinant vacc ...... fficacy of malaria DNA vaccine
@en
P2093
R Hedstrom
S L Hoffman
P2860
P304
P356
10.1073/PNAS.95.13.7648
P407
P577
1998-06-23T00:00:00Z